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Abstract
Non-typeable Haemophilus influenzae (NTHi) is a common acute otitis media pathogen, with an incidence that is increased
by previous antibiotic treatment. NTHi is also an emerging causative agent of other chronic infections in humans, some
linked to morbidity, and all of which impose substantial treatment costs. In this study we explore the possibility that
antibiotic exposure may stimulate biofilm formation by NTHi bacteria. We discovered that sub-inhibitory concentrations of
beta-lactam antibiotic (i.e., amounts that partially inhibit bacterial growth) stimulated the biofilm-forming ability of NTHi
strains, an effect that was strain and antibiotic dependent. When exposed to sub-inhibitory concentrations of beta-lactam
antibiotics NTHi strains produced tightly packed biofilms with decreased numbers of culturable bacteria but increased
biomass. The ratio of protein per unit weight of biofilm decreased as a result of antibiotic exposure. Antibiotic-stimulated
biofilms had altered ultrastructure, and genes involved in glycogen production and transporter function were up regulated
in response to antibiotic exposure. Down-regulated genes were linked to multiple metabolic processes but not those
involved in stress response. Antibiotic-stimulated biofilm bacteria were more resistant to a lethal dose (10 mg/mL) of
cefuroxime. Our results suggest that beta-lactam antibiotic exposure may act as a signaling molecule that promotes
transformation into the biofilm phenotype. Loss of viable bacteria, increase in biofilm biomass and decreased protein
production coupled with a concomitant up-regulation of genes involved with glycogen production might result in a biofilm
of sessile, metabolically inactive bacteria sustained by stored glycogen. These biofilms may protect surviving bacteria from
subsequent antibiotic challenges, and act as a reservoir of viable bacteria once antibiotic exposure has ended.
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Introduction
Non-typeable Haemophilus influenzae (NTHi), a Gram-negative,
rod-shaped bacterium is a common commensal organism in the
human upper respiratory tract. However, NTHi is also an
emerging causative agent of chronic infections in humans [1–3],
imposing a substantial economic burden on health care systems.
For example, NTHi is a major causative agent of acute otitis
media (AOM, middle ear infection) [4–6]. Treatment costs for
otitis media in 2006 were estimated to be $2.8 billion per year [7].
Tympanostomy tube insertion, a common treatment for chronic
serous otitis media [8,9], has a treatment cost of $2,174 per patient
[10]. NTHi has also been linked to community-acquired
pneumonia in children [11], infections in cystic fibrosis patients
[12], and upper respiratory tract infections [13–17]. NTHi can
cause sinus infections [3,18] and has been linked to morbidity in
patients with chronic obstructive pulmonary disease (COPD) [14–
16].
Orally administered beta-lactam antibiotics are the usual
treatment for NTHi infections. For otitis media infections beta-
lactam antibiotics such as amoxicillin, ampicillin or cefuroxime are
used [19,20]. Although antibiotic treatments for otitis media are
generally successful [19,20], antibiotic resistance [21], and the
ability of otitis media bacteria to form antibiotic tolerant biofilms
[6] highlights two major difficulties in treating this disease;
antibiotic resistance and increased susceptibility to re-infection
after treatment. The emergence of antibiotic resistant pathogens in
otitis media has prompted recommendations aimed at limiting
antibiotic exposure in children [22]. The reported possibility of
increased risk of recurrent otitis media after antibiotic treatment
[23] also argue for judicious use of antibiotics in children, as do the
links between antibiotic exposure in early life and increased risk of
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subsequent Crohn’s disease [24] or asthma [25–27]. Previous
antibiotic treatment is also a risk factor for increased occurrence of
acute otitis media caused by NTHi [5], presumably as a result of
antibiotic-induced selection or biofilm formation.
Recent studies suggest that antibiotics may promote biofilm
formation. For example, a broad range of antibiotics can stimulate
in vitro biofilm formation by Staphylococcus epidermidis [28–34].
Similarly, Pseudomonas aeruginosa biofilm formation is induced by
sub-inhibitory concentrations of tobramycin, tetracycline and
norfloxacin [35,36]. In both organisms, biofilm formation in the
presence of sub-inhibitory concentrations of antibiotic is a
consequence of altered gene expression. The modulation of
bacterial gene expression by antibiotics is a well-documented
phenomenon that is usually linked to modification of ribosome
function [35,37,38]. Although we do not yet know how beta-
lactams might modulate gene expression in NTHi bacteria, a
subset of beta-lactams have been reported to induce colanic acid
production in Escherichia coli [39]. In E. coli, colanic acid is
important for maturation of biofilm architecture, so any increase
in its synthesis might exacerbate the formation or persistence of
biofilms [39].
Recognition of the role of biofilm infections in otitis media [6]
has improved our understanding of why chronic and persistent
infections occur, but offers little guidance for successful treatment.
The difficulties of treating biofilm infections, which can be up to
1,000 times more resistant to antibiotics [40], has prompted some
physicians to propose a gradual move away from traditional
antibiotic treatments and toward non-antibiotic therapies [41]. If
antibiotics are to continue to be relevant for treating bacterial
infections it is important that their effects on biofilms be explored.
One step in this direction would be to develop routine screening
methods to test the effects of antibiotics on in vitro formed biofilms.
In this study we have used a biofilm assay model to explore the
effects of exposing newly forming NTHi biofilms in vitro to beta-
lactam antibiotics. We speculated that the increased risk of NTHi
AOM observed after recent antibiotic treatment [5,23] may be a
result of antibiotic-stimulated biofilm formation. We tested this
hypothesis in vitro by exposing NTHi bacteria to increasing
concentrations of beta lactam antibiotic during biofilm formation.
We evaluated the formed biofilms using a classical crystal violet
biofilm assay and compared the results obtained from biofilms
formed in the absence of antibiotic. We also tested the ability of
biofilm bacteria previously exposed to beta-lactam antibiotic to
resist a subsequent challenge from a lethal dose of cefuroxime. We
obtained more accurate measurements of biofilm biomass, protein
content and viable bacteria counts for comparisons and have
examined the biofilms formed by NTHi bacteria in the presence of
beta-lactam antibiotics microscopically. Finally we performed an
analysis of mRNA obtained from biofilm bacteria to determine if
exposure to beta-lactam antibiotics was able to modulate gene
expression in NTHi bacteria.
Methods
Bacterial biofilm cultivation
50 ml from frozen stock cultures of non-typeable Haemophilus
influenzae strains PittAA, PittEE, PittGG, PittII [42,43], 2019 [44]
and 9274 [45] were spread onto chocolate agar plates (Hardy
Diagnostics, Santa Maria, CA, USA) and incubated at 37uC in an
atmosphere of 5% CO2 with 95% relative humidity. After 24-hour
incubation, multiple colonies were used to inoculate BHI broth
(Bacto Brain Heart Infusion; BD Diagnostics, Sparks, MD, USA)
supplemented with hemin (Sigma-Aldrich Inc., St. Louis, MO,
USA) at 10 mg/ml and nicotinamide adenine dinucleotide (NAD)
(Sigma-Aldrich Inc., St. Louis, MO, USA) at 2 mg/ml (sBHI) [46].
The bacterial suspension was grown to stationary phase
(16109 CFU/ml) at 37uC, 5% CO2, with 95% relative humidity.
Biofilms in this study were prepared by diluting 1:200 bacterial
suspensions at stationary phase with fresh sBHI, aliquoting into
culture vessels appropriate for subsequent applications, and
incubating at 37uC with 5% CO2 and 95% relative humidity for
24 hours. All NTHi strains were isolated from chronic otitis media
patients, with the exception of 2019, which was isolated from a
patient with chronic bronchitis.
Antibiotics
Stock solutions of ampicillin, amoxicillin, and cefuroxime (all
from Sigma-Aldrich Inc., St. Louis, MO, USA) were prepared as
follows: ampicillin trihydrate and amoxicillin were dissolved in
pure DMSO, sterilized using a 0.22 mm syringe filter with nylon
membrane (Acrodisc, Pall Corporation, Port Washington, NY,
USA), and aliquoted into sterile cryovials for storage at 220uC.
Cefuroxime sodium salt was dissolved in BHI broth and sterilized
as above. All antibiotic stock solutions were frozen and thawed
once before use. All were used immediately after thawing and then
discarded.
Antibiotic susceptibility test
All NTHi strains in this study were tested for susceptibilities to
ampicillin and cefuroxime, using the Bauer-Kirby disk diffusion
method [47]. Following standard testing procedures and results
interpretive charts provided by the manufacturer, BBL Sensi-Discs
(BD Diagnostics, Sparks, MD, USA) impregnated with 10 mg
ampicillin or 30 mg cefuroxime were applied to growing bacteria
prepared using direct colony suspension method, with H. influenzae
ATCC 49247 and ATCC 49766 (American Type Culture
Collection, Manassas, VA, USA) as control strains for sensitivity
to ampicillin and cefuroxime.
Minimum inhibitory concentrations (MICs) and minimum
bactericidal concentrations (MBCs) were determined on experi-
mental strains by applying BSAC Working Party Report
guidelines [48].
Antibiotic assays
Biofilms were prepared in 96-well tissue culture-treated
polystyrene microplates (BD Biosciences, Bedford, MA, USA)
with beta-lactam antibiotics at designated concentration ranges.
One row of 8 wells was used for each experiment and each well
was read individually. Control rows of wells contained sBHI only
or bacteria in sBHI with no antibiotics. For ampicillin and
amoxicillin assays, additional control wells of bacteria in sBHI
containing corresponding dilutions of DMSO were also set up.
The bacteria were incubated at 37uC in an atmosphere of 5%
CO2 and 95% relative humidity for 24 hours before biofilm
quantification using crystal violet assay.
In order to investigate the ability of NTHi biofilms to resist
lethal doses of beta-lactam antibiotic, biofilms were formed in the
wells of 96 well plates (8 wells per experiment) in the presence or
absence of specific sub-inhibitory concentrations of selected beta-
lactam antibiotics. The formed biofilms were washed with sterile
sBHI and incubated overnight in sBHI containing 10 mg/mL
cefuroxime. The biofilms were scraped, agitated to disrupt the
biofilm and re-suspend the bacteria, and the numbers of viable
bacteria estimated using the drop plate counting method [49].
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Crystal violet biofilm assay
The OD600 of the fully hydrated biofilm-containing wells was
measured using a SpectraMax M5 microplate reader (Molecular
Devices, LLC, Sunnyvale, CA, USA). A crystal violet assay was
then applied to quantify biofilm formation [50–52]. 1% aqueous
solution of crystal violet (Sigma-Aldrich Inc., St. Louis, MO, USA)
was added to the biofilm at 20 ml per well, left for 15 min. and
then washed. After the stained wells were air-dried, DMSO was
added. The OD600 of crystal violet in DMSO solution (absorption
maxima = 600 nm) was measured in a microplate reader.
Biofilm analysis
In order to obtain sufficient material for estimating biofilm
biomass (dry weight) and protein content, NTHi biofilms were
formed in 206100 mm tissue culture-treated polystyrene dishes
(BD Biosciences, Bedford, MA, USA) in the presence and absence
of 170 ng/mL ampicillin (3 replicas each). Antibiotics were present
during biofilm formation. The culture medium was washed from
the formed biofilms with PBS and the biofilm material was freeze-
dried under vacuum. Dry weights were measured from batches of
pooled biofilms (3 dishes each batch). Protein content was
estimated using the BCA Protein Assay Kit (Thermo Scientific
Pierce) on biofilm material scraped from dishes and tabulated as
percent protein content per biofilm. For CFU counts, biofilms
were not dried but were scraped and suspended in sBHI, serially
diluted and estimates of total viable bacteria calculated after 24 hr
incubation [49]. The results were tabulated as numbers of viable
bacteria per mg dry biofilm.
Statistical Analysis
Data from experimental and control conditions were analyzed
using GraphPad Prism (version 6.02, GraphPad Software, Inc., La
Jolla, CA). Groups were compared using an unpaired t test with
Welch’s correction. Statistical significance was defined as P,0.05.
Confocal laser scanning microscopy
NTHi biofilms were prepared in 96-well tissue culture-treated
imaging microplates (BD Biosciences, Bedford, MA, USA).
Fluorescent dyes from FilmTracer Live/Dead Biofilm Viability
kit (Molecular Probes, Inc., Eugene, OR, USA) were applied to
biofilms at the final concentrations of 5 mM and 30 mM, of Syto9
and propidium iodide, respectively. Biofilms were incubated with
the dyes at room temperature for 20–40 minutes before being
imaged by LSM710 Meta NLO cLSM (Carl Zeiss Inc, Thorn-
wood, NY, USA). All cLSM images were collected within a
window of 40–90 minutes after application of the fluorescent dyes.
Scanning electron microscopy
For better specimen handling for processing and examination in
an SEM, plastic coverslips were used as growth substrate for NTHi
biofilms; hence, biofilms were prepared in 206100 mm tissue
culture-treated polystyrene dishes (BD Biosciences, Bedford, MA,
USA) with Thermanox plastic coverslips (Nalgene Nunc Interna-
tional, Rochester, NY, USA) placed at the bottom. Then, as
previously described [22], biofilms on coverslips were fixed by
plunge-freezing in liquid propane, freeze-substituted with ethanol,
gradually warmed to 4uC, and critical point dried. The dried
biofilms were mounted on a specimen stub, sputter coated in
argon with a 18 nm-layer of platinum and examined in the XL 30
SFEG SEM operating at 5 kV in the secondary electron mode
(FEI Company, Hillsboro, OR, USA). Biofilm thickness estimates
were obtained from regions where the biofilm profile was visible.
Transmission electron microscopy
Specimen holders for the EMPact2 high-pressure freezer (Leica
Microsystems IN, Deerfield, IL) were autoclaved and immersed in
BHI medium containing NTHi bacteria (PittGG strain) in the
presence or absence of 170 ng/mL ampicillin and incubated
overnight at 37uC. The specimen holders were removed from
culture, dried on the base and frozen under high pressure. Biofilm
present in the specimen holders were dehydrated while still frozen
[53] and embedded in Lowicryl HM20 resin under UV light while
being maintained at 250uC in an AFS 2 (Leica Microsystems IN,
Deerfield, IL). Embedded biofilms were re-orientated for optimal
sectioning, re-embedded in epoxy resin and sectioned. Thin
sections were mounted on Formvar-coated copper and nickel
specimen grids and contrasted with aqueous solutions of uranyl
acetate and lead citrate.
Glycogen staining was carried out on thin sections before heavy
metal contrasting using a previously described protocol [54].
Sections were treated with 1% aqueous periodic acid for 30 min,
washed and then treated with sodium chlorite prepared in acetic
acid and water as previously described [54]. Periodic acid
exposure was omitted in control experiments [54,55].
Sections were examined with a Tecnai G2 20 transmission
electron microscope (FEI, Hillsboro, OR) and images collected
digitally. Images were compiled into figures using PhotoShop.
Image modifications consisted of brightness and contrast adjust-
ments applied to the whole image. Image cropping was performed
for presentation purposes.
Glycogen Assay
Replicate preparations (4 replicates) of NTHi biofilms were
prepared in Petri dishes using strain Pitt GG in the presence and
absence of 170 ng/mL ampicillin. After 24 hr incubation the
formed biofilms were washed with PBS, scraped from the plastic
substrate, collected in tubes and dried. The dried biofilms were
weighed and a commercially available glycogen assay kit (Abcam
cat # ab65620: www.abcam.com/Glycogen-Assay-Kit-ab65620.
html) was used to estimate glycogen content following the
protocols supplied with the kit.
Gene expression transcriptomic profiling by DNA
microarray
NTHi PittGG bacteria were suspended in sBHI and added to
206100 mm tissue culture-treated polystyrene dishes as described
above and incubated for 24 hr at 37uC. Three biological replicates
per condition were prepared (plus or minus 170 ng/mL ampicil-
lin) and the experiment was carried out as follows.
Briefly, the biofilms were gently washed in PBS to remove
culture medium and then removed from the plastic substrate by
scraping in 4 mL of PBS. The scraped biofilm suspensions were
placed in 50 mL Falcon tubes, evenly dispersed and aliquoted for
further processing. The aliquots were centrifuged at 8,000 rpm in
a benchtop centrifuge (Eppendorf, Hauppauge, NY) for 3 min.
and the supernatant was discarded. The pellets were re-suspended
in RNAwiz and total RNA was extracted using Ambion RiboPure-
Bacteria kit following the manufacturer’s instructions (Life
Technologies Corporation, Carlsbad, CA, USA).
cDNA was synthesized using Invitrogen SuperScript Double-
Stranded cDNA Synthesis Kit (Life Technologies Corporation,
Carlsbad, CA, USA). Both RNA and cDNA quality was checked
using Agilent 2100 Bioanalyzer and Agilent RNA 6000 nano and
DNA1000 chips (Agilent Technologies, Inc., Santa Clara, CA,
USA). cDNA (0.5–1 mg) was used to start the amplification and
labeling reaction using the Roche NimbleGen One-Color DNA
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Labeling kit, in which Cy3 was randomly incorporated in the
newly synthesized DNA by Klenow fragment (3’R5’ exo-).
Two mg of labeled DNA derived from each RNA sample was
hybridized to each array for over 16–18 hours. DNA microarray
gene expression was carried out using Roche NimbleGen custom
whole genome tilling arrays (100910_CW_P_ging_-
W83_expr_HX12) (Roche NimbleGen, Inc., Madison, WI,
USA) according to the standard NimbleGen procedure (Nimble-
Gen Arrays User’s Guide: Gene Expression Analysis v5.1).
The slides/arrays were washed and spun dry and then scanned
using a NimbleGen MS200 Microarray scanner with a resolution
of 2 mm. The normalization was done using NimbleScan 2.6.0.0
built-in normalization function. Microarray data analysis was
performed using Partek Genomics Suite v6.5 (Partek Inc., St.
Louis, MO, USA). Differentially expressed genes were determined
using fold-change ($1.5) plus P (#0.05, T-test) with FDR#0.05.
The gene expression data was deposited in NCBI’s Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo).
Results
Biofilm formation is stimulated by beta-lactam antibiotics
A total of six strains of NTHi bacteria were chosen for this study
based on their origin and history. All were clinical strains but four
had only a limited history of laboratory culture (PittAA, PittEE,
PittII, PittGG). The two other strains, 2019 and 9274 are
considered to be laboratory strains. Crystal violet staining showed
that all the NTHi strains used in this study formed biofilms, as all
resulted in OD600 readings greater than the sBHI control (Fig. 1
and Table S1). The amount of biofilm formation was variable
between strains, reflecting the relative amount of stainable biofilm
material attaching to the surface of 96 well plates. NTHi strain
PittII produced the most biofilm (Fig. 1) while PittAA and PittEE
produced the least (Fig. 1).
Antibiotic resistant varied between the strains as tested using
Sensi-Disc test discs (Table S2). Control strains 49249 and 49766
were resistant or susceptible respectively. Most strains were
susceptible to cefuroxime with PittEE showing an intermediate
reaction. Pitt AA, PittEE and PittGG were resistant to 10 mg
ampicillin. However, MIC’s and MBC’s showed that PittAA and
PittGG were susceptible to lower amounts of ampicillin than
expected. PittAA, resistant to ampicillin as indicated by the test
disc assay was only sensitive to high levels of ampicillin
(MIC = 800 mg/mL; MBC 1,000 mg/mL). MIC and MBC data
is tabulated in Table S2.
We examined the ability of these NTHi strains to form biofilms
in the presence of increasing concentrations of penicillin-based
beta-lactam antibiotics. Some of the NTHi strains reacted to the
antibiotics by producing more biofilm (Fig. 2). Our experiments
showed this stimulatory effect on NTHi strain 2019 in the
presence 90 ng/mL ampicillin (p = ,0.0001) but not in the
presence of ampicillin (Fig. 2 and Table S1). Biofilm production
was stimulated in 9274 by 230 ng/mL amoxicillin and 90 ng/mL
ampicillin (p = 0.002 & 0.0095 respectively). PittAA was stimulated
by 120 ng/mL amoxicillin (p = 0.0003);, PittEE by amoxicillin at
450 ng/mL (p = ,0.0001) and ampicillin at 525 ng/mL (p = ,
0.0001). PittGG and PittII did not appear to react to the presence
of amoxicillin or ampicillin in our chosen concentration range,
even though there were significant differences between the effects
of maximal observed stimulation with unexposed biofilm levels
(Fig. 2 and Table S1). PittGG biofilms reached peaks in crystal
violet assays in the presence of 60 ng/mL amoxicillin (p = 0.0047)
and 170 ng/mL ampicillin (p = 0.0336). PittII reacted to 120 ng/
mL amoxicillin (p = ,0.0001). However, the stimulated levels of
PittGG and PittII in response to amoxicillin were higher than
other biofilms formed in the presence of antibiotic but were lower
than the untreated biofilms.
Cefuroxime, a cephalosporin beta-lactam antibiotic produced a
biofilm stimulatory effect in the range of 0–950 ng/mL on all of
the NTHi strains we studied (p = ,0.0001) (Fig. 2 and Table S1).
Biofilm stimulation occurred at different concentrations depending
on the NTHi strain. PittGG and PittII showed maximum biofilm
stimulation at 220 ng/mL cefuroxime, PittEE at 525 ng/mL,
PittAA and 9274 at 300 ng/mL, and 2019 at 100 ng/mL (Fig. 2).
The strongest and broadest reaction was demonstrated by strain
PittII, where the biofilm stimulatory effect was observed from
170 ng/mL to 400 ng/mL. The NTHi strain least affected by
cefuroxime was PittAA, which showed only a small increase in
biofilm formation at 300 ng/mL (Fig. 2 and Table S1).
The results we obtained for PittGG using the biofilm assay
showed no apparent reaction in the 150 ng/mL dilution of
ampicillin (Fig. 2). The high SD and low p value (0.0336)
prompted us to re-examine the interaction of this strain with a
narrower concentration range of ampicillin. Once we narrowed
the range in which the antibiotic was tested, we were able to detect
a conclusive biofilm-stimulatory effect by ampicillin at a concen-
tration that peaked at 170 ng/mL (p = ,0.0001) (Fig. 3 and Table
S1).
Beta-lactam antibiotics inhibit bacterial growth but
increase biomass and protein content of in vitro formed
biofilms
In order to determine how beta-lactam antibiotics were
affecting the biofilm-forming abilities of NTHi bacteria we assayed
the following; a) total biomass of the formed biofilms; b) protein
content; and c) total number of viable bacteria in the biofilms.
These assays were applied to biofilms formed in the presence and
absence of sub-inhibitory concentrations of beta-lactam antibiotics
and the results presented in Figure 4.
Results from NTHi strain 2019 showed that in the presence of a
sub-inhibitory concentration of ampicillin (94 ng/mL) the NTHi
Figure 1. Biofilm formation is variable between NTHi strains.
Biofilm quantification using crystal violet assay showed the variability in
biofilm formation between the NTHi strains in this study. Relative
Biofilm Quantity was measured as OD600 of crystal violet in DMSO;
higher absorbance indicated more biofilm production. The PittAA and
PittEE strains showed the least amount of biofilm attachment to the
growth surface while PittII showed the most. The other three strains
(2019, 9274 and PittGG) formed intermediate amounts of biofilm
material (t-test analysis in Table S2).
doi:10.1371/journal.pone.0099204.g001
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bacteria produced an increased amount of biofilm biomass (dry
weight in mg per total biofilm per dish). The dry weight increased
from 5.3 mg/dish to 17.3 mg/dish (Fig. 4A). Ampicillin applied to
NTHi strain PittGG under similar conditions, but using a different
maximum stimulatory concentration (161 ng/mL) of antibiotic,
produced similar trends in the biofilm biomass (Fig. 4). The
biomass of the untreated PittGG biofilm was 2 mg/biofilm,
increasing to 44 mg/biofilm when formed in the presence of
ampicillin (Fig. 4A)
The presence of ampicillin resulted in a reduction in the relative
protein composition in the 2019 and PittGG biofilms (Fig. 4B).
While most of the untreated biofilm was composed of protein
(2019: 91%, PittGG: over 100%), ampicillin-treated biofilms
contained less protein (2019: 57%, PittGG: 28%, Fig. 4B).
However, as the total biomass of the biofilm had increased in
the presence of the antibiotic, the total amount of protein detected
in the ampicillin-treated biofilms was more than double that of the
untreated biofilms (for 2019: 4.8 mg/untreated biofilm v. 9.9 mg/
treated biofilm: for PittGG: 2.2 mg/untreated biofilm v. 12.1 mg/
treated biofilm, Fig. 4). The anomalous measurement obtained
from the untreated PittGG biofilm (over 100% protein content)
was most probably due to the inability of the protein assay to
detect the low level of protein present in the biofilm (approx.
2.2 mg/biofilm). This possibility is supported by the large
coefficient of error present in the readings. Additional measure-
ments did not produce more accurate results (data not shown).
The presence of ampicillin reduced the numbers of viable
bacteria (in CFU’s per mg biofilm) in forming biofilms (Fig. 4C).
The numbers of viable bacteria in the 2019 biofilms decreased
from 4.16108 (no ampicillin) to 2.46108 (with ampicillin). Viable
bacteria in the PittGG biofilms decreased from 8.56109 (no
antibiotic) to 1.86108 (with antibiotic).
Figure 2. Biofilm formation is stimulated by beta-lactam antibiotics. Crystal violet assays of 1-day NTHi biofilms formed in the presence of
amoxicillin or amoxicillin. Strains 2019, 9274 and PittEE reacted to inhibitory concentrations of antibiotic (grey vertical bars, Biomass OD600) by
producing more crystal violet stainable biofilm (line graph). This stimulatory effect was different for each bacterial strain. PittGG did not react with
amoxicillin and produced an ambiguous reaction to ampicillin. PittAA and PittII were not affected by amoxicillin or ampicillin in the concentration
ranges studied. Cefuroxime (0–950 ng/mL range) showed a biofilm-stimulatory effect on all the NTHi strains under study. Each strain exhibited
biofilm stimulation in different concentrations of antibiotic. Strain 2019 was maximally stimulated at 100 ng/mL cefuroxime, PittGG and PittII at
220 ng/mL, 9274, PittAA at 300 ng/mL and PittEE at 525 ng/mL.
doi:10.1371/journal.pone.0099204.g002
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Antibiotic resistance does not predict a biofilm
stimulatory response
Presuming that antibiotic resistance may play a role in the
biofilm-stimulatory effect on the NTHi bacteria, we screened all
the strains for antibiotic resistance using routine methods (Table
S2). PittAA and PittEE strains were completely resistant to
ampicillin. All the other strains used in this study did not exhibit
resistance to the remaining three antibiotics. Minimum inhibitory
concentrations (MICs) and minimum bactericidal concentrations
(MBCs) for the NTHi strains occurred over a broad mg/mL range
of dilutions, and much higher than the ng/mL concentration
range used to promote biofilm formation.
Biofilm bacteria survive sub-inhibitory concentrations of
ampicillin
The Live/Dead stain was applied to biofilms formed in the
presence and absence of ampicillin. Untreated biofilms of NTHi
strains 2019 and PittGG contained mostly green-staining small
dots (live bacteria), with only few red (dead) bacteria (Figs. 5A &
C). Untreated PittGG biofilms appeared to contain more regions
of dead bacteria than the 2019 biofilms (Figs. 5C & D).
The presence of sub-inhibitory concentrations of ampicillin
altered the Live/Dead staining patterns in both 2019 and PittGG
biofilms (Figs. 5B & D). Ampicillin-treated biofilms were stained
mostly red, indicating large numbers of structurally compromised
or dead bacteria. However, living (green staining) bacteria were
still present in the ampicillin-treated biofilms (Fig. 5).
Reconstructed Z-series stacks through the biofilms showed
untreated biofilms composed of mostly intact bacteria, and
ampicillin-treated biofilms composed of mostly damaged bacteria
(Figs. 5E–F). The reconstructed stacks showed that all the bacteria
from both NTHi strains were more densely packed at the base of
biofilms even when they were structurally compromised (Figs. 5E–
H). The untreated biofilms formed by 2019 (Fig. 5E) were of lower
height than those formed by PittGG (Fig. 5G), and although it was
difficult to determine where the top of the biofilms were using the
cLSM, the antibiotic exposure did appear to increase the biofilm
thickness in both NTHi strains (Figs. 5F & H). PittGG biofilms
formed in the presence of ampicillin contained large numbers of
Figure 3. PittGG biofilm formation is stimulated by ampicillin in a narrow concentration range. Crystal violet assay of 1-day PittGG
biofilms, formed in the presence of increasing amounts of ampicillin up 300 ng/mL, showed a stimulation of biofilm formation at 170 ng/mL
concentration.
doi:10.1371/journal.pone.0099204.g003
Figure 4. A sub-inhibitory concentration of ampicillin changes the composition of forming NTHi biofilms. Two strains of NTHi, 2019
and PittGG, exposed to sub-inhibitory concentrations (90 ng/mL: 2019; 170 ng/mL: PittGG) of ampicillin for 24 hr, showed increases in biofilm
biomass as measured by dry weight (A. Biomass), and percent protein content (B. Protein Content). In contrast, the presence of the antibiotic during
biofilm formation resulted in a decrease in viable (or culturable) bacteria (C. Viable Bacteria). Strain PittGG showed the most noticeable changes in dry
weight, protein content and numbers of viable bacteria resulting from exposure to 170 ng/mL ampicillin (t-test p = ,0.05).
doi:10.1371/journal.pone.0099204.g004
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structurally compromised bacteria in red stained aggregates. The
Z-stack reconstruction of the ampicillin-exposed PittGG biofilm
revealed clumps of aggregated dead bacteria (Fig. 5H).
Ampicillin affects the morphology of in vitro formed NTHi
biofilms
In order to examine the NTHi biofilms at higher resolution,
biofilms on Thermanox slides formed under sBHI broth were
examined by scanning electron microscopy (SEM). At low
magnification, the biofilm formed by strain 2019 appeared as a
uniformly thick mat covering the substrate (Fig. 6A) with thin
breaks running through the mat, which probably formed during
specimen preparation. At higher magnification, the biofilm, which
could be easily examined between the breaks, was approx. 30 mm
high and consisted of a network of partitions and spaces covered
with a thin layer of amorphous material (Fig. 6B). The partitions
running through the biofilm were composed mostly of aggregated
bacterial cells (Fig. 6C).
NTHi strain 2019 biofilms that formed in the presence of sub-
inhibitory amounts of ampicillin (Figs. 6D–F) were morphologi-
cally similar to the untreated biofilms when examined at low
magnification and had breaks running through the mat (Fig. 6D).
At higher magnification (Fig. 6E), the ampicillin-treated NTHi
2019 biofilm was approx. 40 mm high and was composed of a
network of partitions and spaces covered on the top surface with a
thick amorphous layer. However, when examined more closely,
the partitions in the biofilm appeared to contain fewer aggregated
bacterial cells (Fig. 6F) than in the untreated biofilm (Fig. 6C), and
instead were composed of sheets of amorphous material contain-
ing embedded bacterial cells (Fig. 6F).
PittGG biofilms formed on Thermanox slides were approx.
20 mm high, and therefore thinner than the NTHi 2019 biofilms
(Figs. 6G–I) and had few partitions and spaces. The partitions
were covered with an amorphous layer (Fig. 6) and contained
fewer aggregated bacteria (Fig. 6I) than observed in the 2019
biofilm (Fig. 6C). Ampicillin exposure produced the most striking
morphological changes in the PittGG biofilms. In contrast to
biofilms formed in the absence of antibiotic (Fig. 6G), the biofilms
formed in the presence of ampicillin were thick mats separated by
wide breaks (Fig. 6J). These islands of biofilm were not strongly
attached to the substrate and could be easily dislodged during
processing. The mats were substantially thicker (approx. 80 mm)
than either the untreated PittGG biofilm or the biofilms formed by
the 2019 strain in the presence or absence of antibiotic. As with
the other biofilms, the mats were covered on the top surface with
amorphous material (Fig. 6K) and were composed of partitions
and spaces. The partitions within the biofilm were made from thin
films of amorphous material. Unlike the other biofilms, few
bacterial cells were detected embedded in these partitions (Fig. 6L).
Amoxicillin-stimulated biofilms protect bacteria from a
lethal dose of cefuroxime
Suspensions of planktonic forms of NTHi strains 2019 and
PittGG showed no signs of bacterial growth after an overnight
incubation in 10 mg/mL concentration of cefuroxime (data not
shown), indicating bacterial killing by the high dose of antibiotic.
However, if the two strains of NTHi were first allowed to form a
biofilm and the biofilm bacteria then exposed to the 10 mg/mL
dose of cefuroxime, the antibiotic was unable to completely
eliminate all viable bacteria from the biofilm (Fig. 7).
Exposure to sub-inhibitory concentrations of beta-lactam
antibiotic modified the sensitivity to the subsequent challenge
from the high cefuroxime dose. The modification varied
depending on the strain of NTHi examined and on the first
antibiotic the bacteria encountered (Fig. 7 and Table S1). The
2019 strain showed a significant increased sensitivity to the lethal
dose of cefuroxime after an initial exposure to 170 ng/mL
ampicillin (p = ,0.0001) when compared to bacteria from biofilm
alone (Fig. 7A). However, exposure to 230 ng/mL amoxicillin
produced a decrease in cefuroxime sensitivity (p = ,0.0059).
Exposure to 170 ng/mL of cefuroxime did not change sensitivity
to the subsequent lethal dose of cefuroxime (Fig. 7A) and reacted
in a similar way to bacteria from untreated biofilms (Fig. 7).
The biofilms formed by the PittGG strain showed a different
trend. Exposure to a sub-inhibitory dose of ampicillin significantly
decreased the sensitivity of the PittGG bacteria to the high dose of
cefuroxime (p = ,0.0001, Fig. 7B and Table S3). Bacteria from
biofilms formed in a sub-inhibitory dose of ampicillin were more
sensitive to the high dose of cefuroxime (p = ,0.0001). An initial
Figure 5. Sub-inhibitory concentrations of ampicillin result in
an increase in dead NTHi bacteria in newly formed biofilms.
Confocal laser scanning microscopy (cLSM) of biofilms formed by NTHi
strains 2019 and PittGG in the absence (2 amp) and presence (+ amp)
of sub-inhibitory concentrations of ampicillin were stained using the
LIVE/DEAD viability assay. 2019 were exposed to 90 ng/mL ampicillin
and PittGG to 170 ng/mL ampicillin. Live bacteria were colored green
and dead bacteria red. From above, biofilms formed in the absence of
ampicillin were mostly green (A & C), indicating living (or intact) NTHi
bacteria. Clumps of bacteria in both biofilms stained red (A & C)
indicating the presence of dead, or structurally compromised bacteria.
Biofilms formed by 2019 (A) contained fewer aggregates of red bacteria
than did PittGG (C) contained more. In the presence of ampicillin (B & D)
the bacteria in the biofilms were mostly red, indicating a large number
of dead bacteria. Green-stained bacteria were still present in both
biofilms but appeared more aggregated in the presence of antibiotic (B
& D). Large amounts of aggregated red bacteria were present in both
biofilms, with the aggregates being larger in the PittGG biofilm (Fig. D).
Z-stack projections of the biofilms (E–H) showed that all the biofilms
were denser at the base of the biofilm, whether exposed to ampicillin or
not. In the absence of ampicillin, 2019 (E) and PittGG (G) biofilms
comprised green, or intact bacteria. In the presence of ampicillin the
biofilm contained mostly structurally compromised bacterial cells,
which were colored red or yellow. The 2019 (F) and PittGG (H) biofilms
formed in the presence of ampicillin were higher than the comparable
biofilms formed without exposure to ampicillin (E & G). All images; scale
bar (G) = 20 mm.
doi:10.1371/journal.pone.0099204.g005
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sub-inhibitory dose of cefuroxime did not alter sensitivity to the
subsequent higher dose (Fig. 7B).
Ampicillin affects mRNA expression
In order to determine the underlying molecular cause for
different biofilm phenotype formation in the presence or absence
of a sub-inhibitory dose of ampicillin, we performed microarray
gene expression profiling using Roche NimbleGen whole genome
custom tilling array (126135 K) for H. influenzae and the RNA
from PittGG biofilms formed in the presence and absence of
antibiotic. Principal component analysis (PCA) on microarray
whole transcriptome expression profiling showed that the PittGG
biofilm samples where bacteria (NTHi) were treated with
ampicillin were clearly different from the control samples
(Figure 8). Significant differentially expressed genes (DEGs) were
identified based on fold change ($1.5-fold) plus p value (#0.05)
with a FDR#0.05. The microarray assay identified 59 DEGs that
met the above criteria in the NTHi bacteria treated with 170 ng/
mL ampicillin as compared with the control (Table 1). Eight genes
were up-regulated and 51 were down-regulated. Of the 8 up-
regulated genes 5 were linked to carbohydrate metabolism
(Figure 8), one was involved in pyrimidine metabolism and two
were transporters (an ABC transporter and a sodium: hydrogen
antiporter). Down-regulated genes were less easily grouped based
Figure 6. Sub-inhibitory concentrations of ampicillin change the ultrastructure of newly formed NTHi biofilms. Scanning electron
microscopy (SEM) images comparing NTHi biofilms formed in the absence and presence of ampicillin on Thermanox coverslips. A–C: SEM of 2019
biofilms. A) At low power the 2019 biofilm is seen as a mat covering the Thermanox substrate. Bar = 500 mm. B) higher magnification shows the
biofilm to be composed of partitions forming empty spaces, or cells, covered with a film of amorphous material (arrow). Bar = 10 mm. C) the partitions
within the biofilm are composed primarily of bacterial cells aggregated into flat sheets. Bar = 5 mm. D–F: SEM of 2019 biofilms formed in 90 ng/mL
ampicillin. D) The 2019 biofilm formed with ampicillin covers the substrate. Bar = 500 mm. E) The biofilm is composed of partitions around empty
spaces with a flat sheet of amorphous material (arrow) over the top. Bar = 50 mm F) The biofilm partitions are composed of aggregated bacteria
embedded in sheets of amorphous material. Bar = 5 mm. G–I: SEM of PittGG biofilms. G) The PittGG bacteria form a biofilm over the Thermanox
surface. Bar = 500 mm. H) The biofilm is composed of bacterial cells aggregated into poorly defined partitions and covered with a layer of amorphous
material (arrow). Bar = 10 mm. I) The biofilm is composed of bacterial cells aggregated into widely spaced strands, and empty space. Bar = 5 mm. J–L:
SEM of PittGG biofilms formed in 170 ng/mL ampicillin. J) In the presence of ampicillin the PittGG bacteria form a biofilm comprised of a thick mat,
which appears to be strongly attached to itself but less well attached to the substrate. Bar = 500 mm. K) The biofilm mats appear to be composed
mostly of amorphous material, a layer of which covers the biofilm (arrow), and arranged into tightly-packed thin partitions. Bar = 50 mm. L) the biofilm
is composed of amorphous material formed into thin partitions. The few bacteria detected were embedded in the thin partitions. Bar = 5 mm.
doi:10.1371/journal.pone.0099204.g006
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on their functions because the genes spanned a variety of
metabolic processes, including cell wall synthesis (Table 1 and
Figure 8). However, some of the most down-regulated genes were
also involved with carbohydrate metabolism (Table S4). The gene
expression data has been deposited in NCBI’s Gene Expression
Omnibus and is accessible through GEO Series accession number
GSE58213 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc = GSE58213).
Glycogen was detected in ampicillin-treated NTHi
biofilms
A commercial glycogen assay applied to four replicates of
ampicillin-treated NTHi biofilms detected up to 0.68 mg of
glycogen per mg of biofilm (0.019, 0.028, 0.41 and 0.68 mg/mg,
with a mean of 0.14 mg per mg of biofilm (SD = 0.1). The lowest
calibration point was 0.02 mg on the calibration graph. Glycogen
was not detected at any level in four replicate untreated NTHi
biofilms (data not shown).
Application of a modified Schiff stain to sections through
ampicillin-treated NTHi biofilms revealed the presence of an
extracellular granular substance that we concluded as being
extracellular glycogen (Fig. 9). The presumed glycogen stain was
associated with the biofilm bacteria and did not appear in regions
of the section that were biofilm-free (data not shown). The Schiff
Figure 7. NTHi biofilms protect against a lethal dose of
cefuroxime. Biofilms of NTHi strains 2019 and PittGG were formed
overnight in the absence of antibiotic (Untreated), or in the presence of
170 ng/mL ampicillin (AMP), 230 ng/mL amoxicillin (AMOX) or 170 ng/
mL cefuroxime (CEF). The amounts of antibiotic were chosen for their
ability to stimulate biofilm formation in these two NTHi strains. After
washing, the biofilms were exposed to 10 mg/mL of cefuroxime for a
further 24 hr. The percentages of viable bacteria present in each biofilm
are tabulated here. Not shown: planktonic NTHi bacteria are killed in the
presence of 10 mg/mL cefuroxime. Although all of the formed biofilms
(in the presence or absence of antibiotic) protected against cefuroxime,
the amoxicillin-stimulated biofilm was able to protect bacteria from the
lethal effects of the cefuroxime. p-values are documented in Table S3.
doi:10.1371/journal.pone.0099204.g007
Figure 8. mRNA analysis of PittGG biofilms. A. Principal
component analysis of microarray gene expression of the PittGG
biofilm bacteria (NTHi) exposed to 170 ng/mL ampicillin. The major
variations (PC1, PC2, and PC3) are visualized in 3-dimensions. The three
PCs together accounted for about 85% of the variations present in the
entire data set. A distinguishable grouping difference can be seen
between ampicillin treated (in blue) and non-treated (in red) samples. B.
Hierarchical cluster of significantly differentially expressed genes in the
PittGG biofilm bacteria (NTHi) treated with 170 ng/mL ampicillin.
Heatmap visualization of 59 significantly regulated genes by ampicillin
treatment. Results from the 3 replicate experiments (R1, R2 and R3) of
ampicillin-treated and untreated biofilms are presented. A hierarchical
clustering was analysed on the probe sets representing the 59 genes
including 8 up and 51 down regulated gene transcripts with filter
criteria of at least 1.5 folds change plus P#0.05 and FDR less than 0.05.
Rows: samples; columns: genes. The up-regulated genes relating to
carbohydrate metabolism are indicated.
doi:10.1371/journal.pone.0099204.g008
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Table 1. Significant genes identified by microarray transcriptomic analysis in the biofilm bacteria exposed to 170 ng/mL
ampicillin.
UPREGULATED GENES
Gene NameOrdered Locus Uniprot Fold Change p-Value Biological Process/function
Carbohydrate Metabolism
ADP-glucose synthase glgC NTHI1807 Q4QK69 1.66 0.0008 glycogen biosynthesis
4-alpha-glucanotransferase malQ NTHI1810 Q4QK66 1.58 0.0003 glycosyltransferase
1,4-alpha-glucan branching enzyme glgB NTHI1809 Q4QK67 1.62 0.0007 glycogen biosynthesis
Glycogen operon protein GlgX glgX NTHI1808 Q4QK68 1.55 0.0009 glycogen catabolism
Glycogen synthase glgA NTHI1806 Q4QK70 1.86 0.0003 glycogen biosynthesis
Transporter
Predicted cobalt transport protein NTHI1421 Q4QL56 1.57 0.001 ABC transporter
Pyrimidine Metabolism
Cytidine deaminase cdd NTHI1816 Q4QK60 1.65 0.0006 UMP synthesis
Hypothetical Protein
Uncharacterized protein:pH regulation NTHI0443 Q4QNL4 1.58 0.001 Na:H antiporter activity
DOWNREGULATED GENES
Amino-acid biosynthesis
Bifunctional protein FolD folD NTHI0864 Q4QMI7 22.36 0.001 Amino-acid biosynthesis
Phosphoglycerol transferase-like protein NTHI1918 Q4QJX3 22.09 1E-05 Transferase
Amino Acid Metabolism
Anthranilate synthase component I trpE NTHI1768 Q4QK98 21.52 0.001 Lyase
Peptide methionine sulfoxide reductase msaB NTHI1677 Q4QKI0 21.56 0.001 Oxidoreductase
Glutamate racemase murI NTHI205 Q4QJK7 21.77 0.001 Cell wall biogenesis
Folate Biosynthesis
dihydroneopterin aldolase folB NTHI0372 Q4QNS3 21.71 0.001 Lyase
Purine Metabolism
Bifunctional purine biosynthesis protein purH NTHI1051 Q4QM21 21.98 0.001 Hydrolase
Phosphoribosylaminoimidazole carboxylase ATPase
subunit
purK NTHI1424 Q4QL53 21.96 0.001 Lyase
N5-carboxyaminoimidazole ribonucleotide mutase purE NTHI1425 Q4QL52 23.70 5E-05 Lyase
Phosphoribosylformylglycinamidine cyclo-ligase purM NTHI1704 Q4QKF3 23.45 9E-05 Ligase
Phosphoribosylaminoimidazole-succinocarboxamide
synthase
purC NTHI2033 Q4QJM1 22.50 0.0003 Ligase
Phosphoribosylglycinamide formyltransferase purN NTHI1706 Q4QKF2 22.66 1E-04 Transferase
adenylosuccinase purB NTHI0758 Q4QMS8 21.52 0.001 Lyase
Regulation of transcription
BirA bifunctional protein birA NTHI0323 Q4QNW6 22.63 0.0004 Ligase
Ribose operon repressor rbsR NTHI0634 Q4QN40 21.62 0.001 DNA binding
Xylose operon regulatory protein xylR NTHI1273 Q4QLI5 22.15 9E-05 DNA binding
Toxin biosynthetic process
Colicin V production protein cvpA NTHI1377 Q4QL93 21.92 0.001 Membrane protein
Carbohydrate metabolism
D,D-heptose 1,7-bisphosphate phosphatase NTHI0880 Q4QMH3 23.21 0.0003 Hydrolase
Fructose-1,6-bisphosphatase glpX NTHI0789 Q4QMP9 21.85 0.002 Hydrolase
Acetoacetate CoA transferase alpha subunit atoD NTHI0935 Q4QMC5 21.75 0.0006 Transferase
DNA replication
DNA polymerase III subunit epsilon dnaQ NTHI0223 Q4QP50 22.29 7E-05 Transferase
Ribonuclease H rnhA NTHI0224 Q4QP49 23.09 0.0001 Endonuclease
Protein transporter
Competence protein E comE NTHI0560 Q4QNB0 21.87 0.001 Protein secretion
Type IV pilin secretion protein pilB NTHI0408 Q4QNP5 21.64 0.0006
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stain contrasted material in the extracellular matrix and did not
stain intracellular sites (Fig. 9).
Although it is possible for processing and staining protocols to
produce these contrasting patterns on thin sections we were unable
to replicate them on any control experiments. Ampicillin-treated
biofilm that was not exposed to the staining reagents did not show
contrasted extracellular material (Fig. 9E). Biofilms not exposed to
ampicillin and either treated with the stain reagents (Fig. 9F) on
not treated (Fig. 9G) also did not show any contrasted extracellular
material. The contrasted extracellular material was only present in
sections through ampicillin-treated NTHi biofilms treated with the
modified Schiff stain.
Ampicillin-treated NTHi biofilms contained biofilm bacteria
with variable sizes (Fig. 9). Regular sized bacteria (,500 nm
thickness) were intermingled with NTHi bacteria that were 3 to 5
times larger (Fig. 9), and more spherical in appearance. Although
some of the larger bacteria had a damaged appearance, others
were morphologically intact (Fig. 9). The presence of the larger
bacteria in ampicillin-treated biofilms was independent of whether
the sections had been stained for glycogen, and were absent from
untreated NTHi biofilms (Fig. 9).
Table 1. Cont.
UPREGULATED GENES
Gene NameOrdered Locus Uniprot Fold Change p-Value Biological Process/function
Type IV pilin secretion protein pilC NTHI0407 Q4QNP6 21.74 0.001
Cellular cell wall organization
Membrane-bound lytic murein transglycosylase F mltF NTHI0338 Q4QNV4 22.21 2E-04
Aminoacyl-tRNA biosynthesis
Lysine–tRNA ligase genX NTHI1003 Q4QM64 21.60 0.001
ABC transporter
periplasmic oligopeptide-binding protein oppA NTHI1292 Q4QLH0 21.74 0.0003
ABC-type chelated iron transport system hfeD NTHI0477 Q4QNI3 21.5 0.001
DNA packaging
Phage terminase large subunit NTHI1741 Q4QKB9 22.02 0.001
Protein deacetylation
NAD-dependent deacetylase sirtuin 5 NTHI1634 Q4QKL5 22.80 2E-04 Hydrolase
RNA repair
Multifunctional CCA protein cca NTHI1436 Q4QL41 21.97 0.002
Amino acid transporter
Tryptophan-specific transport protein mtr NTHI0396 Q4QNQ4 21.84 0.0002
Hypothetical Proteins
NTHI0215 Q4QP56 23.28 0.001 transmembrane transport
NTHI0680 Q4QMZ6 21.73 0.0004
NTHI0735 Q4QMU6 21.64 0.0005 Predicated membrane protein
NTHI1330 Q4QLD5 21.64 0.001
Conserved FAD/FMN-containing dehydrogenase NTHI1331 Q4QLD4 21.77 0.001
NTHI1505 Q4QKY1 22.25 0.001
NTHI1511 Q4QKX6 22.54 0.0007 DNA replication
NTHI1528 Q4QKW1 22.17 0.0005
NTHI1534 Q4QKV5 21.84 0.002
NTHI1635 Q4QKL4 24.08 0.001 Catalytic activity
NTHI1721 Q4QKD8 23.11 0.001 DNA binding
NTHI1726 Q4QKD3 21.92 0.0006
NTHI1735 Q4QKC5 22.31 0.001
NTHI1736 Q4QKC4 22.10 0.0008 Cell wall catabolism
NTHI1738 Q4QKC2 22.04 0.0003
NTHI1739 Q4QKC1 22.12 0.0005 DNA binding
Putative recombination protein NinB ninB NTHI1727 Q4QKD2 22.54 0.0006
Putative recombination protein NinG ninG NTHI1728 Q4QKD1 22.49 0.0007
Genes that were either up or down regulated ($1.5-fold plus P#0.05, T-test and FDR#0.05) when biofilms were formed in the presence of 170 ng/mL ampicillin are
listed. Eight genes were up-regulated and 51 were down-regulated. Of the eight up-regulated genes, 5 were involved in carbohydrate metabolism and were enzymes
involved in glycogen processing. The down-regulated genes were involved in a wide range of metabolic processes and 18 genes were unannotated (hypothetical).
doi:10.1371/journal.pone.0099204.t001
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Discussion
The ability of NTHi bacteria to form biofilms in vitro
[50,52,56,57] was exploited here to investigate the stimulatory
effect of sub-inhibitory concentrations of beta-lactam antibiotics
on biofilm formation. We have found that some beta-lactam
antibiotics were able to stimulate, or increase, biofilm formation by
some strains of NTHi bacteria. The amount of antibiotic able to
stimulate biofilm formation was dependent on the antibiotic used
as well as the strain of NTHi that was exposed to the antibiotic.
There was no uniform response across strains, and some strains
did not react to the presence of the antibiotics. The NTHi strains
that reacted to the antibiotic did so at different concentrations and
antibiotic resistance/sensitivity was not a predictor of how a
particular strain would react to sub-inhibitory concentrations of
antibiotic. The biofilm stimulatory effect occurred below the
minimum inhibitory concentration, was observed in a strain that
was antibiotic resistant (PittEE), and was not observed in a strain
susceptible to amoxicillin and cefuroxime (PittAA).
Biofilm stimulation was detected using the crystal violet biofilm
assay, which measures the amount of biological material sticking to
the surface of a container after bacteria have been cultured in it. It
is not clear if this assay is an estimator of an increase in biofilm
biomass or if it detects an increased ability of the biofilm material
to attach to the sides of the plastic wells. For this reason, we
examined the NTHi biofilms using other assays to confirm that
beta-lactam antibiotic exposure was increasing biofilm biomass. In
the presence of ampicillin, two different strains of NTHi showed
an increase in dry weight and total protein content. However,
antibiotic exposure lowered the ratio of protein to biofilm mass.
The antibiotic also resulted in a drop in the number of viable
bacteria in the biofilms, an observation supported by light
microscopy, which showed more dead bacteria in the treated
biofilms. Our direct observation of living biofilms also demon-
strated the presence of antibiotic to cause an increase in the
thickness of the formed biofilms.
Protein content in biofilms has previously been reported to
derive from lysed cells or be actively secreted by biofilm-forming
bacteria [58]. Our observation of decreased protein in the
ampicillin-exposed biofilms might suggest a down-regulation of
protein synthesis, a speculation that was supported by the
comparison of mRNA from untreated and antibiotic-treated
biofilms. The increase in biofilm biomass could also be partially
explained by our mRNA analysis, which showed an up-regulation
of genes involved with glycogen production in the presence of
antibiotic. Glycogen, being a multi-unit sugar, would not be
detected in a protein assay but its presence could account for the
increased biomass we observed.
The increase in biomass may offer an explanation for why the
ampicillin-stimulated PittGG biofilm was less firmly attached to
the plastic surface after drying for SEM examination. The added
volume and biofilm bulk could make an already weakly attached
biofilm more easily dislodge during specimen preparation.
Although it is possible that attachment mechanisms of the biofilm
or biofilm bacteria have been modified by exposure to antibiotic,
any such modifications were not evident in the mRNA data we
collected.
The loss of bacterial cells after antibiotic exposure may indicate
the expected massive cell death, and subsequent lysis, that
theoretically may influence biofilm formation by chemical and
physical aggregation lacking a biological component [59].
However, it must be considered that the bacteria in our
experiment are adopting the biofilm phenotype that is by
definition less able to grow under laboratory conditions. Trans-
formation into the biofilm phenotype would mean that the NTHi
bacteria become less culturable and less likely to be detected in
viability assays, a common phenomenon observed for biofilm
bacteria [60].
The composition of the partition walls we observed in the
biofilms at the ultrastructural level is still a mystery. Increased
production of glycogen might suggest that as the source of the
partition wall material, a speculation that is currently being tested.
The TEM examination of ampicillin-treated biofilms to detect
glycogen did not reveal cross sections of partition walls, rather the
glycogen in the ECM appeared globular and in close proximity to
bacterial cells. The loss of bacterial cells in biofilms exposed to
antibiotic might be due to massive cell death, which would liberate
cytoplasmic proteins into the ECM and which could aggregate
around nucleation sites such as provided by extracellular DNA
[61] and form specific structures such as partition walls. The
partition walls we observed were similar to ultrastructural features
Figure 9. Ultrastructural visualization of glycogen in PittGG
biofilms. Resin-embedded thin sections of PittGG biofilms formed in
the presence or absence of ampicillin (+/2 Am) and treated with a
glycogen stain or a no stain control (+/2 gly). A–D Biofilms with
ampicillin, sections stained for glycogen (periodic acid and sodium
chlorite). The glycogen stain reacted with an extracellular granular
substance (arrows) that was associated with biofilm bacteria. Exposure
to antibiotic resulted in a bacterial size increase with some bacteria (A–
C). Extracellular areas that were not in close proximity to bacteria cells
(asterisk) did not contain the extracellular granular substance (B–D). E.
Biofilm with antibiotic but only treated with sodium chlorite did not
reveal extracellular granular substance. Large bacterial cells were
present. F. Biofilm with no antibiotic, sections stained for glycogen.
No extracellular granular substance was detected and bacterial cells had
a normal diameter (approx. 500 nm). Some lysed cells were detected. G.
Biofilm with no antibiotic, treated with sodium chlorite (no periodic
acid). Bacterial cells appear normal with a few dying cells present
(arrowhead). Scale bars = 500 nm.
doi:10.1371/journal.pone.0099204.g009
b-Lactams Stimulate Glycogen and Biofilm Formation
PLOS ONE | www.plosone.org 12 July 2014 | Volume 9 | Issue 7 | e99204
observed in biofilms from other bacteria [62–65]. Although it is
still unclear what these partitions are composed of, proteins and
DNA are common components of the extracellular matrix of
biofilms formed by NTHi [50,66,67] and other bacteria
[61,63,68–77]. Extracellular protein has been shown to remain
functional in NTHi biofilms, maintaining the structural integrity of
extracellular DNA, and perhaps forming DNA nets [67]. It is
possible that the partitions observed in maturing biofilms as well as
biofilms formed in the presence of biofilm-stimulating antibiotics
result from extracellular protein, carbohydrate or glycogen
aggregating on nets of extracellular DNA [61].
We selected beta-lactam antibiotics to study because these are
the class of antibiotics most commonly used to treat patients with
otitis media [22]. Although we used a common biofilm assay that
bears little similarity to biofilms that might be formed in otitis
media patients (in that middle ear epithelial cells were absent) we
think it was appropriate to begin with a simple system where
conditions could be controlled. A move to more complex and
sophisticated biologically relevant models can be made once basic
mechanisms have been elucidated.
Amoxicillin concentrations that have an in vitro biofilm
stimulatory effect are in the range of 230–450 ng/mL. These in
vitro amounts are much lower than recorded peak concentrations
of amoxicillin in the middle ear fluids taken from otitis media
patients, where the mean concentration was 9.5 mg/mL [78].
However, amoxicillin concentrations in the middle ear fluids range
from undetectable to 20.6 mg/mL [78], a range broad enough to
fit our experimental concentrations.
Recommended treatment protocols for otitis media consist of
oral administration of amoxicillin, or amoxicillin combined with
clavulanic acid, a beta-lactamase inhibitor [3,22]. Recurrence, or
lack of resolution of the infection can then be treated with a course
of a different antibiotic, such as cefuroxime. These treatment
protocols are very similar to those recommended for treating acute
bacterial rhinosinusitis [3]. Using our in vitro system, we performed
a preliminary experiment to mimic the treatment protocol where
bacteria are first exposed to a sub-inhibitory dose of one antibody
and then challenged with a higher dose of cefuroxime, a common
antibiotic used to treat recalcitrant NTHi infections. Both the
2019 and PittGG strains showed that biofilm formation is
important for protecting bacteria from a subsequent high dose of
cefuroxime. Amoxicillin exposure appeared to increase the
resistance of 2019 biofilm bacteria to a subsequent lethal dose of
cefuroxime. Ampicillin exposure protected PittGG biofilm bacte-
ria from the subsequent cefuroxime exposure. A sub-inhibitory
dose of beta-lactam antibiotic influencing a subsequent antibiotic
challenge is an effect that might occur under conditions in patients
undergoing treatment for otitis media. It is thus worth further
investigation. The phenomenon of increased resistance to a second
course of antibiotics may help explain the increased occurrence of
acute otitis media caused by NTHi [5] after an initial antibiotic
course of treatment.
Outpatient beta-lactam antibiotics are mostly orally adminis-
tered. Thus, the pharmacological bioavailability of the antibiotics
may not be homogeneous throughout the body, with local
concentrations being influenced by body weight, percent fat,
gender, and drug accessibility. Bacterial biofilms are present
throughout the human body [79] so it is highly likely that
antibiotic treatments will impact commensal bacteria in uninfected
regions of the body. If NTHi bacteria in the body react to beta-
lactam antibiotics in a similar way to our in vitro observations, it is
possible that an immediate and less desirable side effect of beta-
lactam treatment of otitis media would be to stimulate bacterial
attachment to surfaces within the body. Such a stimulus for
attachment may signal a change in the NTHi causing it to become
a pathogenic form. As such, these biofilm bacteria could then
become a source of future chronic infections. Beta-lactam-treated
patients would be expected to have an increased risk of recurrent
infection. In fact, observations of otitis media patients do indicate
an increased risk of recurrent otitis media after antibiotic
treatment [23]. Increased occurrence of NTHi AOM is a
consequence of previous antibiotic treatment [5].
While it has been reported that azithromycin can decrease
established NTHi biofilms and inhibit NTHi biofilm formation
[80], there appear to be few studies examining the effects of
antibiotics stimulating NTHi biofilm formation. Antibiotics have
been reported to stimulate biofilm formation in Staphylococcus
epidermidis [28–34], Pseudomonas aeruginosa [35,36], and Escherichia
coli [39]. These reports, as well as the findings we report in this
paper, all support the recently proposed theory that antibiotics
may act as inter-microbial signaling molecules [35,81] enabling
microorganisms to communicate with each other.
Conclusions
We have shown that sub-inhibitory concentrations of amoxicil-
lin, ampicillin and cefuroxime (beta-lactam antibiotics) will
stimulate NTHi bacteria to produce more biofilm biomass even
as the numbers of culturable bacteria decline and as the biofilm
protein content decreases. Biofilm bacteria were protected from
the toxic effects of a high dose of cefuroxime. The biofilms formed
in the presence of sub-inhibitory concentrations of antibiotic were
thicker, had altered ultrastructure and contained increased
numbers of dead bacteria. Sub-inhibitory concentrations of
antibiotic up-regulated genes involved with glycogen biosynthesis,
and glycogen was detected in antibiotic-treated biofilms. Genes
encoding transporters and one gene involved with pyrimidine
metabolism were also up-regulated. Surprisingly, genes involved
with stress responses were not up-regulated. A total of 51 genes
were down-regulated and were involved in a variety of metabolic
processes, including cell-wall biosynthesis. Our results suggest that
exposure to sub-inhibitory concentrations of beta-lactam antibiotic
cause NTHi bacteria to increase glycogen synthesis while turning
down a broad range of other metabolic processes. Beta-lactam-
stimulated NTHi biofilms may protect embedded bacteria from
subsequent high concentrations of cefuroxime.
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